The Great CDH1 Debate: Surgery or Surveillance? Understanding Your Options for Managing Hereditary Stomach Cancer Risk

For CDH1 carriers, choosing between ongoing surveillance and preventive gastrectomy is one of the most personal and complex decisions they’ll ever face. On Thursday, July 16, 2026, at 4:00 p.m. EST, join Jeremy L. Davis, MD (University of Maryland) and Monika Laszkowska, MD (Memorial Sloan Kettering Cancer Center) for a thoughtful, science‑driven conversation exploring the risks, benefits, and individualized decision-making behind both approaches. This session will help you understand why patients choose differently—and how to navigate your own path with clarity and confidence.